Significance of combined TGF-1 and survivin expression on the prognosis of patients with triple-negative breast cancer

被引:7
作者
Liu, Nannan [1 ]
Qi, Dongxue [2 ]
Jiang, Jing [3 ]
Zhang, Jihong [3 ]
Yu, Chunyan [1 ,4 ]
机构
[1] Beihua Univ, Coll Basic Med, Dept Pathol, Jilin 132013, Peoples R China
[2] Lianyungang First Peoples Hosp, Dept Pathol, Lianyungang 222000, Jiangsu, Peoples R China
[3] Beihua Univ, Dept Pathol, Affiliated Hosp, Jilin 132011, Peoples R China
[4] Beihua Univ, Coll Basic Med, Dept Pathol, 3999 Binjiang East St, Jilin 132013, Peoples R China
关键词
TGF-beta; 1; survivin; triple-negative breast cancer; non-triple-negative breast cancer; immunochemistry assay; GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION; SPLICE-VARIANTS; DOWN-REGULATION; POOR-PROGNOSIS; KAPPA-B; CELLS; TGF-BETA-1; APOPTOSIS;
D O I
10.3892/ol.2022.13313
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Compared with other types of breast cancer, triple-negative breast cancer (TNBC) has the characteristics of rapid progression, a lack of specific molecular targets for treatment and a poor prognosis. However, based on previously published studies, TGF-beta 1 and survivin are potentially meaningful for the prognosis of patients with TNBC. The present study was therefore designed to measure and compare the expression of transforming growth factor-beta 1 (TGF-beta 1) and survivin in tissue samples of TNBC and non-TNBC patients in order to evaluate their ability as prognostic indicators. In total, 90 TNBC and 52 non-TNBC tissue specimens were selected, following which immunohistochemistry was used to detect the expression of TGF-beta 1 and survivin in the cancer tissues. Subsequently, the potential association between the expression levels of these two proteins and the clinicopathological variables was analyzed. The expression levels of TGF-beta 1 and survivin in TNBC tissues were found to be significantly higher compared with those in the non-TNBC tissues. In addition, the results of the present study demonstrated that TGF-beta 1 expression was positively associated with survivin expression in the TNBC samples, but no significant correlation was found between TGF-beta 1 and survivin expression in the non-TNBC samples. Kaplan-Meier (K-M) analysis was performed to assess the levels of TGF-beta 1 and survivin in regard to patient survival, and univariate and multivariate Cox analyses of TGF-beta 1 and survivin protein expression were performed to analyze the overall survival (OS) and progression-free survival (PFS) rates of patients with TNBC and non-TNBC. Although multivariate Cox analysis demonstrated that neither TGF-beta 1 or survivin were independent prognostic predictors of TNBC or non-TNBC, results of the K-M curve revealed that patients with TNBC with TGF-beta 1- and survivin-positive breast cancer exhibited shorter OS and PFS times. Multivariate Cox analysis demonstrated that in patients with TNBC, the combined expression of TGF-beta 1 and survivin may yield additional prognostic information, compared with patients with non-TNBC.
引用
收藏
页数:12
相关论文
共 58 条
[1]   Subtyping of Triple-Negative Breast Cancer: Implications for Therapy [J].
Abramson, Vandana G. ;
Lehmann, Brian D. ;
Ballinger, Tarah J. ;
Pietenpol, Jennifer A. .
CANCER, 2015, 121 (01) :8-16
[2]   Overexpression of survivin in pediatric Hodgkin lymphoma tumor cells: Characterization of protein expression and splice-variants transcription profile [J].
Alejandro Lorenzetti, Mario ;
Jimena Mosna, Maria ;
Noemi De Matteo, Elena ;
Garcia Lombardi, Mercedes ;
Lorena Colli, Sandra ;
Victoria Preciado, Maria .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2019, 108 :24-31
[3]   Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling [J].
Azim, Hatem A., Jr. ;
Michiels, Stefan ;
Bedard, Philippe L. ;
Singhal, Sandeep K. ;
Criscitiello, Carmen ;
Ignatiadis, Michail ;
Haibe-Kains, Benjamin ;
Piccart, Martine J. ;
Sotiriou, Christos ;
Loi, Sherene .
CLINICAL CANCER RESEARCH, 2012, 18 (05) :1341-1351
[4]   TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer [J].
Bhola, Neil E. ;
Balko, Justin M. ;
Dugger, Teresa C. ;
Kuba, Maria Gabriela ;
Sanchez, Violeta ;
Sanders, Melinda ;
Stanford, Jamie ;
Cook, Rebecca S. ;
Arteaga, Carlos L. .
JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (03) :1348-1358
[5]   Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease [J].
Bianchini, Giampaolo ;
Balko, Justin M. ;
Mayer, Ingrid A. ;
Sanders, Melinda E. ;
Gianni, Luca .
NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (11) :674-690
[6]   Triple-negative breast cancer in the older population [J].
Boyle, P. .
ANNALS OF ONCOLOGY, 2012, 23 :7-12
[7]   RETRACTED: TGF-β Regulates Survivin to Affect Cell Cycle and the Expression of EGFR and MMP9 in Glioblastoma (Retracted article. See vol. 54, pg. 7551, 2017) [J].
Chen, Wenliang ;
Zhong, Xiao ;
Wei, Yi ;
Liu, Yun ;
Yi, Quan ;
Zhang, Genshui ;
He, Lishan ;
Chen, Fajiang ;
Liu, Yingping ;
Luo, Jiandong .
MOLECULAR NEUROBIOLOGY, 2016, 53 (03) :1648-1653
[8]   Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies [J].
Chen, Xun ;
Duan, Ning ;
Zhang, Caiguo ;
Zhang, Wentao .
JOURNAL OF CANCER, 2016, 7 (03) :314-323
[9]  
Chu JS, 2004, J FORMOS MED ASSOC, V103, P925
[10]   The role of Survivin as a biomarker and potential prognostic factor for breast cancer [J].
da Veiga, Glaucia Luciano ;
Machado da Silva, Raissa Daniel ;
Pereira, Edimar Cristiano ;
Azzalis, Ligia Ajaime ;
Aguiar Alves, Beatriz da Costa ;
Gehrke, Flovia de Sousa ;
Gascon, Thais Moura ;
Affonso Fonseca, Fernando Luiz .
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (06) :893-901